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Taurine is one of the most abundant free amino acids in the brain. In a number of studies, taurine has been reported to activate glycine
receptors (Gly-Rs) at moderate concentrations (100M), and to be a weak agonist at GABAA receptors (GABAA-Rs), which are usually
activated at high concentrations (1 mM). In this study, we show that taurine reduced the excitability of thalamocortical relay neurons
and activated both extrasynaptic GABAA-Rs and Gly-Rs in neurons in the mouse ventrobasal (VB) thalamus. Low concentrations of
taurine (10–100 M) decreased neuronal input resistance and firing frequency, and elicited a steady outward current under voltage
clamp, but had no effects on fast inhibitory synaptic currents. Currents elicited by 50M taurine were abolished by gabazine, insensitive
tomidazolam, and partially blocked by 20MZn2, consistent with the pharmacological properties of extrasynaptic GABAA-Rs (42
subtype) involved in tonic inhibition in the thalamus. Tonic inhibitionwas enhanced by an inhibitor of taurine transport, suggesting that
taurine can act as an endogenous activator of these receptors. Taurine-evoked currents were absent in relay neurons from GABAA-R4
subunit knock-out mice. The amplitude of the taurine current was larger in neurons from adult mice than juvenile mice. Taurine was a
more potent agonist at recombinant 42 GABAA-Rs than at 122 GABAA-Rs. We conclude that physiological concentrations of
taurine can inhibit VB neurons via activation of extrasynaptic GABAA-Rs and that taurine may function as an endogenous regulator of
excitability and network activity in the thalamus.
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Introduction
Taurine (2-aminoethane sulfonic acid) is one of the most abun-
dant free amino acids in the brain and is required for the normal
development of the nervous system (Neuringer and Sturman,
1987; Neuringer et al., 1987). It has a variety of physiological
effects (Huxtable, 1992) that have attracted the attention of phar-
macologists (Gupta et al., 2005), yet not all of its effects have been
satisfactorily explained to date. The local application of taurine to
central neurons typically inhibits firing (Curtis and Watkins,
1960) via activation of a Cl conductance. Taurine is a structural
analog of the inhibitory neurotransmitters glycine and GABA,
and activates both glycine and GABAA receptors. For example,
low tomoderate concentrations (200M to 1mM)of taurine have
been shown to activate glycine receptors in the basolateral amyg-
dala (McCool and Botting, 2000), hippocampus (Wu and Xu,
2003), nucleus accumbens (Jiang et al., 2004), supraoptic nucleus
(Hussy et al., 1997), and inferior colliculus (Xu et al., 2004),
whereas high concentrations of taurine (1–10 mM) activate
GABAA receptors in these brain regions.
In addition to classical fast synaptic inhibition that ismediated
byGABA and glycine in the CNS, a novel formof tonic inhibition
has been described, first in the cerebellum (Brickley et al., 1996),
and then in the dentate gyrus (Nusser and Mody, 2002) and
recently in the relay neurons of the thalamus (Porcello et al.,
2003; Belelli et al., 2005; Cope et al., 2005; Jia et al., 2005; Chandra
et al., 2006). Tonic inhibition results from the continuous activa-
tion of extrasynaptic GABAA receptors containing -subunits, in
response to low concentrations of ambient GABA. In the thala-
mus, extrasynaptic GABAA receptors have distinct pharmacolog-
ical properties that differentiate them from synaptic GABAA re-
ceptors (consisting mainly of 1, 2, and 2 subunits). GABA-
mediated tonic inhibition in thalamus also requires expression of
the GABAA receptor 4 subunit, because tonic currents are ab-
sent in thalamic relay neurons from GABAA receptor 4 subunit
knock-out (Gabra4/) mice (Chandra et al., 2006).
In this study, we investigated the actions of taurine in the
mouse ventrobasal (VB) thalamus, and found that taurine, at low
concentrations in the physiological range (10–100M) (Lerma et
al., 1986; Albrecht and Schousboe, 2005), is a potent inhibitor of
VB neurons, where it elicits a conductance increase and tonic
current that is blocked by gabazine, a selective GABAA receptor
antagonist. In addition, we studied the actions of taurine at
42GABAA receptors heterologously expressed in human em-
Received July 12, 2007; revised Nov. 13, 2007; accepted Nov. 14, 2007.
This work was supported by National Institutes of Health Grants AA 16393 (N.L.H.), AA 13004 and GM 47818
(G.E.H.), and GM 066840 (P.A.G.). We thank Carolyn Ferguson for expert assistance. We also thank Felix Wolf
[Research Animal Resource Center (RARC), Weill Medical College, Cornell University, New York, NY] and the RARC
staff for their assistance.
Correspondence should be addressed to either Dr. Fan Jia or Dr. Neil L. Harrison, Department of Anesthesiology,
Weill Cornell Medical College, 1300 York Avenue, Room A-1050, New York, NY 10065-4897. E-mail:
faj2002@med.cornell.edu or neh2001@med.cornell.edu.
DOI:10.1523/JNEUROSCI.3996-07.2008
Copyright © 2008 Society for Neuroscience 0270-6474/08/280106-10$15.00/0
106 • The Journal of Neuroscience, January 2, 2008 • 28(1):106–115
bryonic kidney 293 (HEK293) cells, where taurine showed
greater efficacy than GABA. Taurine was also more potent at
42 receptors than at “synaptic” 122s GABAA receptors.
The taurine-activated current was absent in VB neurons from
Gabra4/ mice, which lack extrasynaptic GABAA receptors
containing the 4 subunit (Chandra et al., 2006). Our data sug-
gest that taurinemay act as an important endogenousmodulator
of thalamic activity in vivo, via the activation of extrasynaptic
GABAA receptors in VB neurons.
Materials andMethods
Electrophysiological recordings in brain slices. Experiments were per-
formed in accordance with institutional and federal guidelines, using
mice (C57BL/6, Gabra4/, and Gabra4/) between 23 and 50 d old
(except for the experiments in Figure 5, which were done with 8- to
10-d-old C57BL/6 mice). Animals were anesthetized with halothane and
brains were removed and placed in ice-cold slicing solution, which con-
tained the following (in mM): 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 220
sucrose, 11 glucose, 10 MgSO4, and 0.5 CaCl2, before cutting horizontal
slices (300 m thick) on a microslicer (VT1000S; Leica, Wetzlar,
Germany).
Slices were perfused with carbongenated artificial CSF (aCSF), which
contained the following (in mM): 124 NaCl, 2.5 KCl, 2 MgSO4, 2 CaCl2,
26 NaHCO3, 1.25 NaH2PO4, and 10 glucose. Whole-cell patch-clamp
recordings from visually identified thalamic neurons were performed
using an Axopatch 200A amplifier (Molecular Devices, Sunnyvale, CA)
as previously described (Jia et al., 2005). Intracellular solution for
voltage-clamp recordings contained the following (in mM): 130
CsCH3SO3, 8.3 NaCH3SO3, 1.7 NaCl, 1 CaCl2, 10 EGTA, 2 ATP-Mg
2,
0.3 GTP-Na, 10 HEPES; pH was adjusted to 7.2 with CsOH. Intracel-
lular solution for current-clamp recordings contained the following (in
mM): 130 K-gluconate, 5 NaCl, 2MgCl2, 10 HEPES, 0.5 EGTA, 2 ATP-
K, and 0.3 GTP-Na, pH adjusted to 7.25 with KOH. During voltage-
clamp recordings, spontaneous IPSCs (sIPSCs) were recorded at 0 mV
and isolated by bath application of 3–5 mM kynurenic acid (Jia et al.,
2005). Access resistance was monitored throughout the recording pe-
riod; cells were included for analysis only if the series resistance was20
M, and change of series resistance was 20% over the course of the
experiment. Off-line analysis was performed using MiniAnalysis 5.5
(Synaptosoft, Decatur, GA), SigmaPlot 6.0 (SPSS, Chicago, IL), and Ex-
cel 2000 (Microsoft, Redmond,WA). The holding current shift wasmea-
sured as the difference between the holding current in the presence and
absence of drug. IPSCs were detected and analyzed usingMiniAnalysis as
previously described (Jia et al., 2005). Unless otherwise indicated, all
numeric data are expressed as mean SEM. The statistical significance
of results was assessed using Student’s t test, and a level of p 0.05 was
considered significant. Drugs were dissolved in aCSF and applied by
perfusion. All compounds were obtained from Sigma (St. Louis, MO),
except guanidinoethyl sulfonate (GES), which was purchased from To-
ronto Research Chemicals (North York, Ontario, Canada).
Recordings fromHEK293 cells expressing recombinant GABAA receptors.
The cDNAs encoding the human 1, mouse 4, rat 2, human 2s, and
human  subunits were subcloned into the pcDNA3.1 expression vector
and transiently expressed in HEK293 cells (American Type Culture Col-
lection, Manassas, VA), and recorded as described by Jia et al. (2005).
Ligand-gated currents were recorded at room temperature (voltage
clamped at 60 mV) using an Axopatch 200 amplifier (Molecular De-
vices). The extracellular solution contained the following (in mM): 145
NaCl, 3KCl, 1.5CaCl2, 1MgCl2, 6 D-glucose, 10HEPES, andpHadjusted
to 7.4 with NaOH. Patch pipettes were filled with the intracellular solu-
tion, which contained the following (inmM): 145N-methyl-D-glucamine
hydrochloride, 0.1 CaCl2, 5 ATP-K
, 1.1 EGTA, 2MgCl2, 5 HEPES, and
pH adjusted to 7.2withKOH.GABAor taurinewas rapidly applied (50
ms exchange time) to the cell via a multichannel motor-driven solution
exchange device (Rapid Solution Changer RSC-100; Molecular Kinetics,
Pullman,WA). Concentration–response data for each individual cell was
fitted (using a sum of least squares method) to a Hill equation of the
form: I  Imax  [agonist]
nH/([agonist]nH  EC50
nH), where I is the
peak current, Imax is the maximum whole-cell current amplitude, [ago-
nist] is the agonist concentration, EC50 is the agonist concentration elic-
iting a half-maximal current response, andnH is theHill coefficient (Jia et
al., 2005). Averaged data are expressed asmean SEM. Statistical signif-
icance was assessed using Student’s t test, and a level of p  0.05 was
considered significantly different.
Generation and use of 4 subunit knock-out mice. 4 subunit gene
knock-out mice were generated as described previously (Chandra et al.,
2006). All knock-out (Gabra4/) and wild-type (Gabra4/) litter-
mates used were age-matched and were on the same genetic background
(129X1/S1 C57BL/6J hybrid; F2–F4 generations). Experimenters were
blind to genotype in all studies.
Results
Taurine decreases the excitability of thalamic neurons in the
ventrobasal complex
We began by asking whether taurine (50 M) could alter the
excitability of thalamic relay neurons. At resting membrane po-
tentials (about 75 mV), most VB neurons in our recordings
displayed “burst” firing in response to depolarizing current steps
(Jahnsen and Llina˜s, 1984; Huguenard, 1996). To facilitate mea-
surements of firing rate, we depolarized their membrane poten-
tials to about 60 mV by constant current injection. At this
membrane potential, VB neurons were generally silent but dis-
played sustained action potential (AP) firing in response to de-
polarizing current steps. The amplitude of the current step (500
ms duration) was adjusted to induce 10 APs (Fig. 1A), corre-
sponding to a firing frequency of20Hz.We then compared the
numbers of APs evoked by depolarizing current steps before and
after taurine application. Taurine (50 M) significantly reduced
the number of evoked APs, from 9.8 1.0 to 7.2 1.1 ( p 0.01;
n 5), and this effect was fully reversible on removal of taurine
(Fig. 1A,B). In addition to the effect on spike firing, taurine (50
M) hyperpolarized the neurons by 2.0 0.8 mV (n 5). Tau-
rine (50 M) also decreased the membrane input resistance (Rm)
to 90 3% of control ( p 0.01; n 5), and this effect was also
fully reversible (Fig. 1C). In the presence of TTX (0.5M), taurine
(50M) still reducedRm to 91 2%of control ( p 0.05; n 4),
which suggests that the inhibitory effect of taurine on Rm is inde-
pendent of fast voltage-gated Na channels, and therefore also
independent of intact synaptic transmission.
We investigated the contribution of glycine receptors to the
inhibitory effects of taurine in an additional set of experiments by
adding strychnine (1 M), a selective glycine receptor antagonist
(Fig. 1D). In the presence of strychnine, taurine (50 M) still
reduced the number of evoked APs (control, 9.6  0.5; taurine,
7.3  0.8; n  6; p  0.01), and hyperpolarized the neurons by
2.2 0.8mV (n 6). The subsequent application of gabazine (10
M) increased the number of APs to 11.9 0.8 ( p 0.01; n 6)
and blocked the effects of taurine. Taurine also decreased Rm to
91 1% of control ( p 0.01; n 6) in the presence of strych-
nine, but the subsequent application of gabazine blocked this
effect of taurine and increased Rm to 108 1% of control ( p
0.01; n 6) (Fig. 1F). We also used depolarizing current steps to
evoke burst firing in VB neurons held near70 mV. The ampli-
tude of the injected current pulse was adjusted to be just above
threshold level for burst firing in the control condition. In all five
neurons tested, the evoked burst firingwas reversibly inhibited by
taurine (50 M); a typical recording is shown in supplemental
Figure 1 (available at www.jneurosci.org as supplemental mate-
rial). Together, these data suggest that 50M taurine reduced the
excitability of VB neurons mainly via an action on GABAA
receptors.
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Taurine evokes outward currents in VB
neurons under voltage clamp
Voltage-clamp recordings were obtained
from VB neurons (in the presence of
kynurenic acid to block ionotropic gluta-
mate receptors; holding potential, 0mV) to
explore the pharmacological properties of
the ionic currents elicited by taurine. In ev-
ery VB neuron from mice older than post-
natal day 22 (P22), we found that taurine
(50M) elicited a steady and sustained out-
ward current (Fig. 2A); the mean ampli-
tude of the taurine-activated currents was
67  13 pA (n  6). When glycine recep-
tors were blocked by 1 M strychnine, tau-
rine currentswere slightly smaller in ampli-
tude (44  5 pA; n  16; p 	 0.05 vs
control). When we used gabazine (10 M),
a selective GABAA receptor antagonist,
much smaller current responses were ob-
served in response to 50M taurine (11 3
pA; n  8; p  0.001 vs control), which
suggests that a small component of the
taurine-evoked currentwas likelymediated
by glycine receptors. The dominant contri-
bution of GABAA receptors to the currents
elicited by taurine (Fig. 2A) is consistent
with the results of the current-clamp ex-
periments (Fig. 1).
At high concentrations (e.g., 500 M
taurine), we recorded large outward cur-
rents (580 33 pA; n 8) (Fig. 2B). These
large taurine-induced currents were re-
duced in amplitude in the presence of ei-
ther strychnine (321  38 pA; n  7; p 
0.05) or gabazine (371 81 pA; n 7; p
0.05), and when strychnine (1 M) and
gabazine (10M)were applied in combina-
tion, the response to taurine was abolished
(2 3 pA; n 9) (Fig. 2B), indicating that
currents activated by high concentrations
of taurine are mediated, equally but exclu-
sively, by a combination of glycine and
GABAA receptors. We then constructed a
series of concentration-response curves for
taurine in the presence and absence of the
two antagonists (Fig. 2C). Closer examina-
tion of these curves at lower concentrations
of taurine (100 M) clearly indicates that
taurine preferentially activated GABAA re-
ceptors rather than glycine receptors (Fig.
2D). In fact, at 10M taurine, the responses
were completely blocked by gabazine (con-
trol, 12 2 pA, n 12; gabazine, 0 1 pA,
n  8), although taurine has been de-
scribed as a more potent agonist at glycine
receptors.
To investigate the possibility of syner-
gistic effects between taurine and GABA,
we also coapplied taurine and GABA in the presence of strych-
nine (1 M). GABA itself (1 M) evoked a modest outward cur-
rent (18 5 pA;n 7).When taurinewas applied in the presence
of GABA (1M), the taurine-induced currents were smaller than
under control condition at all concentrations tested, although
this differencewas not significant (10M, 9 4 pA, n 4; 50M,
39 13 pA, n 7; 100M, 69 12 pA, n 5; p	 0.05 vs control
group at all three concentrations). There is, therefore, no evi-
Figure 1. Taurine decreases the excitability of VB neurons through GABAA receptors. A, Representative current-clamp traces
demonstrate AP firing evoked by a 0.1 nA current step (duration, 500 ms) in a VB neuron. Membrane resistance (Rm) was
measured by injecting hyperpolarizing current (0.02 nA). After taurine (50M) perfusion, AP firing decreased. The inhibitory
effects of taurinewere completely reversible onwashing out taurine.B, Pooled data show that taurine reduces the excitability of
VB neurons (**p 0.01; n 5). C, Bar graph illustrates the normalized Rm from the same (as in B) VB neurons (**p 0.01).
Under control conditions, Rmwas 267 11M, whereas in the presence of taurine and after thewashout of taurine, Rm values
were 242 15 and 267 8M, respectively.D, Representative current-clamp trace demonstrating AP firing evoked by a 0.1
nA current step (duration, 500 ms) in another VB neuron; after taurine (50 M) perfusion, AP firing decreased. Subsequent
gabazine application increased the number of evoked APs. Strychnine (1M) was present throughout the recordings to prevent
the activationof glycine receptors.E, Pooleddata show that taurine reduces the excitability of VBneurons (**p0.01 vs control;
n 6). Gabazine was able to block the inhibition produced by taurine (**p 0.01 vs control; n 6). F, Bar graph illustrates
parallel changes (as in E) inmembrane resistance (Rm) produced by taurine and gabazine (**p 0.01 vs control; n 6). Under
control conditions, Rmwas 234 19M, whereas in the presence of taurine and taurine plus gabazine, Rmwas 213 17 and
253 20 M, respectively. Error bars represent SE.
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dence for synergistic interactions between GABA and taurine,
which is consistent with the idea that both taurine and GABA are
activating the same population of GABAA receptors in the
thalamus.
IPSCs are insensitive to taurine
There have been no previous reports indicat-
ing that taurine activates native GABAA re-
ceptors in this low concentration range (10–
100 M), and we set out to establish the
molecular identity of the GABAA receptors
responsible for generating these currents. All
of the experiments described below were
therefore performed in the presence of
strychnine (1 M) to isolate taurine-evoked
currents mediated by GABAA receptors. In
the presence of 1M strychnine, glycine (100
M) failed to evoke an outward current, and
thus any currents activated by taurine in the
presence of strychnine were mediated only
by GABAA receptors.
In thalamic VB neurons, synaptically lo-
calized GABAA receptors consist primarily
of 1, 2, and 2 subunits, and sIPSCs are
readily observed in VB neurons. All sIPSCs
that we recorded could be blocked by gaba-
zine (Fig. 2), indicating that they were medi-
ated by GABAA receptors. Taurine (50 M)
had no effect on either IPSC amplitude or
decay time (Fig. 3A). The pooled data from
this set of experiments (Fig. 3B) confirm that
the properties of these sIPSCs were not sig-
nificantly affected by 50 M taurine (ampli-
tude: control, 55 5 pA, taurine, 53 5 pA,
p 	 0.05; decay time constant: control,
14.5  1.3 ms, taurine, 14.8  1.4 ms, p 	
0.05; frequency: control, 7.8  1.1 Hz, tau-
rine, 7.8  1.1 Hz, p 	 0.05; n  11). Thus,
taurine (50M) does not appear to modulate
the function of synaptic GABAA receptors in
VB neurons.
Pharmacology of taurine-evoked currents
in VB
We have previously shown that Zn2 par-
tially blocks the tonic gabazine-sensitive
current in VB neurons, whereas the benzo-
diazepine midazolam has no effect on tonic
inhibition (Jia et al., 2005). We investigated
the pharmacology of taurine responses using
midazolam and Zn2. Midazolam (500 nM)
had no effect on the amplitude of the out-
ward current induced by taurine (current re-
duction: 1  1 pA, n  7, p 	 0.05) (Fig.
3C,F ), whereas Zn2 (20 M) partially
blocked the outward current (current reduc-
tion: 23  4 pA, n  6, p  0.01) (Fig.
3D,F ), and gabazine completely blocked the
taurine-activated currents (current shift:
61 6 pA, n 7) (Fig. 3E,F ). We also tested
1M Zn2 so as to distinguish between /
 and  GABAA receptors (Draguhn et
al., 1990; Smart et al., 1991; Storustovu and
Ebert, 2006). In the presence of 50 M tau-
rine, 1 M Zn2 failed to induce an appreciable change in the
holding current (0.7  0.9 pA; n  4); thus, it is unlikely that
GABAA receptors consisting only of  and  subunits contrib-
ute to taurine-evoked currents.
Figure2. Lowconcentrationsof taurinepreferentiallyactivateGABAAreceptors.A, Exemplar tracesof taurine-inducedcurrents
inaVBneuronvoltageclampedat0mV(hereand insubsequent figures).Applicationof50Mtaurineevokedamodest (50pA)
outward current inaVBneuron,whereas in thepresenceof theGABAA receptor antagonistgabazine, 50Mtaurineproducedvery
little current shift in a different VB neuron. In another VB neuron, 50M taurine produced amodest (50 pA) current shift in the
presence of the glycine receptor antagonist strychnine. The bars above the traces indicate the period of drug application at the
indicatedconcentration inthisandsubsequent figures.B, Exemplarcurrent tracedemonstratingthatapplicationof500Mtaurine
evoked large outward currents in VB relay neurons (the scale bars here are different from those inA). In the presence of GABAA or
glycine receptors antagonist, 500M taurine still elicited current shifts in each instance, but had no effect on the holding current
whenbothGABAA andglycine receptors areblocked.All traces are fromdifferentVBneurons.C, Concentration–response curves of
taurine-activated currents in the absence or presence of GABAA and glycine receptors antagonist applied individually. Taurine-
activated currentsmediated byGABAA receptors are larger than currentsmediated by glycine receptors. Error bars represent SE.D,
Concentration–response curves in C were enlarged to illustrate the differences in current amplitude evoked by taurine of low
concentrations (10–100M). Taurine-activated currentsmediated by GABAA receptors are significantly larger than currentsme-
diatedbyglycine receptors.Whenglycine receptorswereblockedbystrychnine, taurineevokedconcentration-dependentoutward
currents in thalamic relayneurons. Controlgroup:10M,11.84.3pA,n6;50M,66.812.7pA,n6;100M,133.8
21.5pA,n5; strychninegroup: 10M,12.41.8pA,n12; 50M,43.65.3pA,n16; 100M,103.413.0pA,n
8;gabazinegroup:10M,0.40.8pA,n8;50M,11.13.0pA,n8;100M,29.45.0pA,n5.ErrorbarsrepresentSE.
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Taurine can act as a direct endogenous
agonist at thalamic extrasynaptic
GABAA receptors
Taurine has been shown to inhibit GABA
uptake mechanisms in the CNS via GABA
transporters 2 (GAT-2) and 3 (GAT-3)
(Liu et al., 1993; Takanaga et al., 2001). To
examine whether taurine might be indi-
rectly activating GABAA receptors by in-
creasing ambient GABA, we studied the
effect of 1-[2-[tris(4-methoxy-phenyl)-
methoxy]ethyl]-( S)-3-piperidinecar-
boxylic acid (SNAP-5114) (50 M), which
inhibits both GAT-2 and GAT-3 (Borden
et al., 1994a; Borden, 1996). We found that
SNAP-5114 alone had no effect on mem-
brane current in VB neurons (0.3 2.3 pA;
n  8) (Fig. 4A,C) and that taurine (50
M) evoked a current shift in the presence
of SNAP-5114 (47  7 pA; n  5), which
was comparable with that reported above
for taurine alone, suggesting that taurine
does not increase ambient GABA levels via
GAT-2/3-dependent heteroexchange
mechanisms in our preparation. These data
argue against a significant contribution of
an indirect effect of taurine on extrasynap-
tic GABAA receptors.
We also studied the effects of coapplied
1-[2-[[(diphenylmethylene)imino]oxy]-
ethyl]-1,2,5,6-tetrahydro-3-pyridinecar-
boxylic acid hydrochloride (NO-711) (10
M; a GAT-1 inhibitor) (Borden et al.,
1994b) and SNAP-5114 (50 M) (Fig.
4A,C), and recorded a current shift of
193  38 pA in response to these two
inhibitors in combination (n  4); this
presumably reflects activation of recep-
tors by endogenous GABA. In the pres-
ence of NO-711 and SNAP-5114, the
sIPSC decay time was also increased,
from 14.5  1.0 to 27.2  2.5 ms. In the
presence of NO-711 and SNAP-5114,
taurine (50 M) application evoked an
outward current (27  7 pA; n  4),
which was not dissimilar from that re-
corded under control conditions (Fig.
4D,E). The small decrease in the taurine-evoked current un-
der these conditions suggests that extrasynaptic GABAA recep-
tors may have been partly desensitized by the sustained in-
crease in ambient GABA induced by extensive GAT blockade
with SNAP-5114 and NO-711.
We next investigated the taurine reuptake inhibitor GES to
determine whether reducing taurine uptake could indirectly ac-
tivate extrasynaptic GABAA receptors in the thalamus. In the
presence of 1 M strychnine, concentrations of GES as low as 10
M were able to induce detectable currents in VB neurons (Fig.
4B). Higher concentrations of GES evoked bigger currents (10
M: 22 4 pA, n 8; 50M: 106 19 pA, n 5; 100M: 215
31 pA, n  7) (Fig. 4C). GES-induced (100 M) currents were
totally blocked by gabazine (n  3). These experiments suggest
that taurine could act as an endogenous agonist for thalamic
extrasynaptic GABAA receptors.
Taurine evokes smaller currents in VB neurons of young
mice (P8–P10)
Inpreviouswork, 500Mtaurinewas reported to reducemembrane
resistance of thalamic relay neurons from young rats, mostly via
activation of glycine receptors (Ghavanini et al., 2005), whereas our
data in adult mice suggest that there is a significant contribution of
GABAA receptors (Fig. 2). To resolve this apparent discrepancy, we
tested taurine in VB neurons of young mice (P8–P10) in the pres-
ence of strychnine. Taurine elicited much smaller currents in these
neurons than in recordings from mature mice (Fig. 5). The mean
amplitude of the taurine-evoked currents were as follows: 10 M,
0.1 0.7 pA (n 4); 50M, 6.5 4.7 pA (n 9); 100M, 16.2
11.1 pA (n 8); p 0.001 versus	P22 group at all three concen-
trations. It therefore appears that thalamic extrasynaptic GABAA
receptors are not fully expressed in these young animals and con-
tinue to increase during adolescence.
Figure 3. The effects of taurine on synaptic versus extrasynaptic GABAA receptors. A, A typical recording of sIPSCs in a VB
neuron in the presence of 50M taurine. Strychnine (1M) was present throughout so as to exclude the contribution of glycine
receptors (aswell as recordings in Figs. 4 and6). Averaged sIPSC traces (	100eventsper ensemble trace) before (black) andafter
(gray) taurine application; superimposed traces illustrate the similarity in amplitude and decay time. B, The normalized ampli-
tude (0.97 0.06), decay time constant (1.03 0.03), and frequency (1.03 0.09) of sIPSCs after 50M taurine perfusion.
These parameters are not significantly different from those obtained under control conditions ( p 	 0.05; n  11). C, A
representative current trace demonstrating that in the presence of 50M taurine, 500 nM midazolam did not shift the baseline
current. D, In a different neuron than in C, ZnCl2 (20M) partially blocked the taurine-induced outward current as evidenced by
the small (20pA) shift in the current baseline.E, In a different neuron than inC andD, gabazine (10M) effectively blocked the
taurine-induced outward current as well as all sIPSCs. The shift in the current baseline is60 pA. F, Averaged current shifts
produced by gabazine (n 7), Zn 2 (n 6), and midazolam (n 7) after taurine application. Error bars represent SE.
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Taurine-evoked currents in HEK cells expressing GABAA
42 and122s receptors
The synaptic GABAA receptors present in VB neurons are
thought to be the 122 subtype (Zhang et al., 1997; Okada et
al., 2000), whereas the extrasynaptic receptors are thought to
represent the 42 subtype (Jia et al.,
2005). To study the taurine sensitivity of
“synaptic” and “extrasynaptic” GABAA re-
ceptor subtypes in a controlled setting, we
studied the effects of taurine on two popu-
lations of recombinant GABAA receptors,
122s and 42, using heterologous
expression in HEK293 cells. Taurine was
more potent in activating 42 receptors
than at 122s (Fig. 6), with a threshold
concentration of 300 M taurine and an
EC50 (7.5 1.3mM; n 12) that was lower
than that observed for the 122s recep-
tors (21.2  7.3 mM; n  8; p  0.05).
Taurine threshold concentrations in HEK
cells were somewhat higher than those in
slice recordings; the disparity may result
from the differences in the technique for
agonist application, or from the effects of
unknown intracellular modulator(s) of ex-
trasynaptic GABAA receptor function in
VB neurons. We compared the efficacy of
taurine andGABA at bothGABAA receptor
subtypes. Itaurinemax (maximum taurine
current) was larger than
IGABAmax in 42 receptors (145  12%;
n  12), whereas Itaurinemax was smaller
than IGABAmax in 122s receptors (70
9%; n 8). The relative efficacy of taurine
at 42 receptors with respect to GABA
[i.e., (Itaurinemax/IGABAmax)] is significantly
larger than was the case at 122s recep-
tors ( p 0.001). In this set of experiments,
the relativemaximal currents quoted above
represent the mean SEM of the maxima
estimated from the curve fits for each indi-
vidual experiment.
Taurine-evoked currents are absent in
VB neurons fromGabra4/mice
We also examined neurons in the reticular
thalamic nucleus (RTN) for the presence of
taurine-evoked currents, but no significant
current shifts were detected (10 M tau-
rine: 0.1  1.6 pA, n  7; 50 M taurine:
1.8  0.8 pA, n  6). We have previously
demonstrated that extrasynaptic GABAA
receptors are absent in the thalamus of
Gabra4/ mice (Chandra et al., 2006),
andwe therefore investigated the actions of
taurine in VB neurons from Gabra4/
mice and their wild-type littermates (Fig.
7). No significant taurine-evoked currents
were detected in VB neurons from 4
knock-outmice (10M: 1 1 pA, n 6; 50
M: 2 1 pA, n 6). In contrast, wild-type
neurons showed measurable taurine-
activated outward currents (10 M: 14 4
pA, n  8; 50 M: 54  13 pA, n  7), which were comparable
with taurine-induced currents recorded from standard C57BL/6
mice. This difference between the genotypes was highly signifi-
cant ( p  0.001 at both concentrations). These results are con-
sistent with the idea that low concentrations of taurine selectively
Figure 4. Endogenous taurine directly evokes GABAergic currents in VB neurons. A, An exemplar current trace (top) demon-
strating that SNAP-5114 (50M), aGAT-2 andGAT-3 inhibitor, failed to induce a current shift in aVBneuron. Anappreciable shift
in the baseline current was observed after coapplication of SNAP-5114 and a second reuptake inhibitor, NO-711 (10M; bottom
trace). B, Exemplar current trace showing that GES (10 M), a taurine uptake inhibitor, evoked current shift (20 pA) in a
different VB neuron than in A. GES (50M) induced a greater outward current (100 pA) in a different VB neuron (note the
different vertical scale bar here from that for 10M GES trace). C, Bar graph demonstrates that GES induced significant outward
currents in VB neurons (10M: 21.5 3.9 pA, n 8; 50M: 105.5 18.9 pA, n 5; 100M: 215.3 31.2 pA, n 7),
whereas SNAP-5114 induced little outward current (50 M: 0.3  2.3 pA, n  8). Coapplication of NO-711 (10 M) and
SNAP-4114 (50M) also produced a significant outward current (193.4 37.9; n 4).D, Sample current traces demonstrating
the effect of taurine (50M) on the outward current in the presence of SNAP-4114 (50M; top trace) or SNAP-4114 plus NO-711
(10M; bottom trace). E, Bar graph summarizing the effect of SNAP-5114 (50M), alone and in combination with NO-711 (10
M), on taurine (50 M)-evoked currents. Control taurine currents were from Figure 2. In the presence of SNAP-5114 alone,
taurine produced a 46.6 7.1 pA current shift (n 5),whereas taurine alone produced a 67 13pA current shift (n 6; same
data as in Fig. 2); taurine again produced a somewhat smaller outward current (26.8 6.6 pA; n 4) in the presence of
SNAP-5114 and NO-711. Error bars represent SE.
Figure 5. Expression of taurine-evoked currents is age dependent. A, Taurine (50M) failed to evoke a current shift in a VB
neuron from a P9 mouse. Taurine (100M) produced small outward current (20 pA) in a VB neuron from a P8 mouse. B, Bar
graph demonstrates that taurine (10, 50, and 100M) induced much smaller currents in VB neurons from young mice (10M,
0.1 0.7 pA, n 4; 50M, 6.5 4.7 pA, n 9; 100M, 16.2 11.1 pA, n 8; ***p 0.001 vs	P22 group at all three
concentrations). Data for age	P22 group are from Figure 2C. Error bars represent SE.
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activate extrasynaptic GABAA receptors that contain 4/ sub-
units (Jia et al., 2005), which are present in VB neurons of wild-
type mice, but not in RTN neurons or in VB neurons from the
knock-out animals (Chandra et al., 2006).
Discussion
Taurine is known to act as an agonist at glycine andGABAA-Rs in
the brain (Albrecht and Schousboe, 2005). Most previous studies
have found that taurine preferentially activates strychnine-
sensitive glycine receptors, whereas very high concentrations
(1–10mM) of taurine also activate GABAA-Rs (Hussy et al., 1997;
del Olmo et al., 2000; McCool and Botting, 2000; Wu and Xu,
2003; Jiang et al., 2004; Xu et al., 2004). This study represents the
first report that low micromolar concentrations (10–100 M) of
taurine can activate GABAA-Rs in the brain. It is likely that these
levels of taurine are achieved in the environment of these recep-
tors, because levels of extracellular taurinemeasured bymicrodi-
alysis range from1 to 10M in the resting state to 120M after
depolarization or other activating stimuli (Lerma et al., 1986;
Albrecht and Schousboe, 2005).
Previous electrophysiological studies using thalamic brain
slices have demonstrated that tonic inhibition is sensitive to
Zn2, but not benzodiazepines (Belelli et al., 2005; Cope et al.,
2005; Jia et al., 2005), consistent with the idea that it is generated
via extrasynaptic GABAA-Rs (consisting of 4, 2, and  sub-
units). We observed that taurine-sensitive GABAA-Rs displayed
remarkably similar pharmacological properties to those of tha-
lamic extrasynaptic GABAA-Rs in being partially blocked by
Zn2 (20 M) but unaffected by midazolam (500 nM). Further-
more, taurine had no effect on inhibitory synaptic currents in VB
neurons, which are mainly mediated by 122 GABAA-Rs
(Zhang et al., 1997;Huntsman andHuguenard, 2000), again sup-
porting the idea that taurine activates extrasynaptic GABAA-Rs
preferentially.
A selective action of taurine on extrasynaptic GABAA-Rs was
also supported by the experiments in RTN neurons. The main
GABAA receptor subunits found in the RTN are 3, 3, and 2
(Pirker et al., 2000), and tonic inhibition is notably absent inRTN
neurons (Belelli et al., 2005; Cope et al., 2005; Jia et al., 2005),
consistent with a lack of expression of extrasynaptic GABAA-Rs;
accordingly, we did not observe taurine-activated currents in
RTN neurons.
Additional supporting evidence was provided by recordings
made using neurons fromGABAA-R4 subunit knock-outmice.
We demonstrated previously that gabazine has little effect on the
holding current in thalamic VB neurons from Gabra4/ mice
(Chandra et al., 2006). GABAA-Rs containing 4/ subunits are
located extrasynaptically (Jia et al., 2005), so the absence of the
tonic current in Gabra4/ VB neurons is consistent with a loss
of these extrasynaptic receptors. Likewise, taurine (10 and 50M)
failed to evoke significant current shifts in VB neurons from
Gabra4/ mice, which indicates that extrasynaptic GABAA-Rs
are the major target of taurine in the thalamus.
Although taurine has been reported to inhibit GABA uptake
through effects on GAT-2 and GAT-3 (Liu et al., 1993; Takanaga
et al., 2001), it seems unlikely from our experiments that taurine
achieves its effects in the thalamus purely via an increase in am-
bient GABA concentrations, because a combination of SNAP-
5114, a GAT-2 and GAT-3 inhibitor, and NO 711, a GAT-1 in-
hibitor, couldmimic, but not occlude, the effects of taurine in VB
neurons. These observations argue against an indirect action of
taurine on GABAA-Rs. Consistent with our conclusion that tau-
rine acts directly on extrasynaptic GABAA-Rs, it is known that
there are high levels of 3H-taurine binding in the dentate gyrus,
cerebellum, and thalamus (Bureau and Olsen, 1991), and it is of
interest that these brain regions also express high levels of the
GABAA-R  subunit (Pirker et al., 2000; Farrant and Nusser,
2005).
Mammalian GABAA-Rs are pentameric structures consisting
of distinct subunits, and different subunit compositions result in
receptors with distinct pharmacological profiles (Sieghart and
Sperk, 2002). We examined the taurine sensitivity of heterolo-
gously expressed GABAA-Rs configured to resemble the native
extrasynaptic (42) and synaptic (122s) receptors. We
Figure 6. Comparison of taurine-evoked Cl currents recorded in HEK293 cells expressing
122s and 42 GABAA receptors. A, Typical concentration-dependent taurine-
activated and maximum GABA-activated currents recorded from42 GABAA receptors ex-
pressed in HEK293 cells. B, Typical concentration-dependent taurine-activated and maximum
GABA-activated currents recorded from122s GABAA receptors. C, Averaged relative con-
centration–response curves (Itaurine/IGABA-max) for 122s (n 8) and 42 (n 12)
GABAA receptors. The averaged concentration–response data in the figure were fitted using a
sum of least-squares method to a Hill equation of the form: I Imax [agonist]
n H/([ago-
nist]n H EC50
n H), where I is the peak current, Imax is the maximumwhole-cell current ampli-
tude, [agonist] is the agonist concentration, EC50 is the agonist concentration eliciting a half-
maximal current response, and nH is the Hill coefficient. Error bars represent SE.
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found that taurine was a more potent agonist at 42 receptors
expressed in HEK293 cells than at 122 receptors. We also
observed that taurine, like THIP (gaboxadol), has a high efficacy
at 42 GABAA-Rs relative to GABA itself, which is a partial
agonist at these receptors.
These findings are in agreement with those of other studies in
 subunit-containing GABAA-Rs; for example, it has been shown
that low concentrations of taurine activate currents in heterolo-
gously expressed 6 GABAA-Rs (Bianchi and Macdonald,
2003; Hadley and Amin, 2007). Together, all of these findings in
recombinant GABAA-Rs suggest that taurine is selective for
GABAA-Rs containing the  subunit over those containing the 
subunit.
In previous work in the rat thalamus, taurine was reported to
activate glycine receptors selectively in thalamic relay neurons
(Ghavanini et al., 2005, 2006), whereas the present data suggest
that there is a significant contribution of GABAA-Rs to the tau-
rine response in themouse thalamus (Fig. 2). One possible expla-
nation for this difference in results is that Ghavanini and col-
leagues used young (P13–P15) rats, whereas we used older (P23–
P50) mice. In young rats, there was no effect of bicuculline (50
M) on the membrane potential or input resistance of thalamic
relay neurons (Ghavanini et al., 2005), which suggests a low level
of extrasynaptic GABAA-R expression in the thalamus of the im-
mature rat. In fact, our data in younger mice (P8–P10) support
the idea that there is a delayed development of thalamic extrasyn-
aptic GABAA-Rs, because taurine (10–100 M) evoked much
smaller currents in neurons from young mice than those from
older animals. A similar developmental increase of tonic inhibi-
tion has been reported in rat cerebellar granule cells (Brickley et
al., 1996), which parallels the developmental time course of 
subunit expression.
Extrasynaptic GABAA-Rs play an important role in regulating
excitability at the level of individual neurons andwithin neuronal
networks (Semyanov et al., 2004). Additionally, an increasing
body of evidence from diverse studies suggests that tonic inhibi-
tion mediated by extrasynaptic GABAA-Rs can play a role in the
regulation of seizure susceptibility (Brooks-Kayal et al., 1998;
Dibbens et al., 2004; Peng et al., 2004; Maguire et al., 2005).
Extrasynaptic GABAA-Rs have been proposed as an important
novel target for therapeutic development (Richerson, 2004; Se-
myanov et al., 2004). It has been known for some time that tau-
rine has antiseizure activity against tonic-
clonic seizures (Gupta et al., 2005).
Exogenously administered taurine may
also have a beneficial effect during with-
drawal from chronic ingestion of alcohol
(Gupta et al., 2005), a hyperexcitable state
that is also accompanied by changes in the
expression of the GABAA-R  subunit
(Cagetti et al., 2003; Liang et al., 2006).
GABAA-Rs containing the  subunit are re-
ported to be sensitive to low concentrations
of ethanol (Sundstrom-Poromaa et al.,
2002; Wallner et al., 2003; Wei et al., 2004;
Hanchar et al., 2005; Glykys et al., 2007). In
light of the present data, it seems likely that
taurine might exert antiseizure effects, at
least in part, by virtue of its agonist activity
at extrasynaptic GABAA-Rs containing the
 subunit, resulting in an increase in con-
ductance that reduces network excitability.
However, one should keep inmind that the
etiology of absence seizures is quite different from that of gener-
alized seizures, and that under the right conditions, hyperpolar-
ization of thalamic relay neurons by taurine can potentially pro-
mote burst firing, as reported for gaboxadol (Cope et al., 2005),
and might therefore actually predispose the brain to the genera-
tion of absence seizures. Clearly, the overall contribution of tau-
rine to epileptogenesis remains to be elucidated.
In conclusion,we demonstrate that low concentrations of tau-
rine can activate extrasynaptic GABAA-Rs and reduce the excit-
ability of thalamic relay neurons in vitro. In the brain, taurine has
been reported to be released in response to hypo-osmotic stimu-
lation, energy deprivation, and membrane depolarization (Oja
and Saransaari, 2000). Taurine can be released from glia (Hol-
opainen et al., 1989; Philibert et al., 1989; Koyama et al., 1994;
Bres et al., 2000) and neurons (Holopainen et al., 1989; Schous-
boe and Pasantes-Morales, 1989; Van Vliet et al., 1989), and the
release mechanisms appear to involve volume-sensitive anion
channels (Hussy et al., 2001) and taurine transporters (Saransaari
and Oja, 1999). Several lines of evidence indicate that extrasynaptic
GABAA-Rsare theprincipal siteofaction for taurine in the thalamus.
The total taurine concentrations measured in brain homogenates
range from 6 to 20 mM (Palkovits et al., 1986), whereas the levels of
free extracellular taurine, asmeasuredbymicrodialysis in vivo, range
from1 to 10M in the resting state to 120Mafter depolarization
or other stimuli (Lerma et al., 1986; Albrecht and Schousboe, 2005).
Given these observations, it seems entirely plausible that taurine acts
as an endogenous ligand at extrasynaptic GABAA-Rs, because we
observed significant inhibitory responses within this physiologically
relevant concentration range (10–100M)(Fig. 2), and the resultsof
our experiments using the taurine transporter inhibitor, GES, seem
to support this idea. The activation of extrasynaptic GABAA-Rs by
taurinemay therefore have important physiological and pathophys-
iological effects: to modulate thalamic network activity under a va-
riety of physiological conditions, and perhaps also to protect neu-
rons from toxicity under pathological conditions (Louzada et al.,
2004).
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